Advertisement
U.S. markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
6.70-0.28 (-4.01%)
At close: 04:00PM EDT
6.40 -0.30 (-4.48%)
After hours: 05:43PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close6.98
Open6.95
Bid6.67 x 400
Ask6.69 x 400
Day's Range6.67 - 7.11
52 Week Range4.07 - 21.05
Volume697,848
Avg. Volume1,353,577
Market Cap423.703M
Beta (5Y Monthly)1.65
PE Ratio (TTM)N/A
EPS (TTM)-0.18
Earnings DateJun 19, 2024 - Jun 24, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-51% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CDMO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Avid Bioservices, Inc.
    Daily – Vickers Top Buyers & Sellers for 01/11/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    3 months agoArgus Research
View more
  • GlobeNewswire

    Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q

    TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received a notice (the “Notice”) on March 19, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure t

  • GuruFocus.com

    Avid Bioservices Inc (CDMO) Releases Preliminary Q3 Financial Results

    Insights into Revenue, Gross Profit, and Operational Performance

  • GlobeNewswire

    Avid Bioservices Announces Pricing of Private Placement of Convertible Notes

    TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the “2029 Notes”). In connection with the offering, the company entered into private placement purchase agreements with the several purchasers, each of whom is a “qualified institutional buyer” within the meaning o